Patents by Inventor David K. LEUNG

David K. LEUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quiesce reconfigurable data processor
    Patent number: 11928512
    Abstract: A reconfigurable data processor comprises an array of configurable units configurable to allocate a plurality of sets of configurable units in the array to implement respective execution fragments of the data processing operation. Quiesce logic is coupled to configurable units in the array, configurable to respond to a quiesce control signal to quiesce the sets of configurable units in the array on quiesce boundaries of the respective execution fragments, and to forward quiesce ready signals for the respective execution fragments when the corresponding sets of processing units are ready. An array quiesce controller distributes the quiesce control signal to configurable units in the array, and receives quiesce ready signals for the respective execution fragments from the quiesce logic.
    Type: Grant
    Filed: May 17, 2021
    Date of Patent: March 12, 2024
    Assignee: SambaNova Systems, Inc.
    Inventors: Raghu Prabhakar, Manish K. Shah, Pramod Nataraja, David Brian Jackson, Kin Hing Leung, Ram Sivaramakrishnan, Sumti Jairath, Gregory Frederick Grohoski
  • Imaging methods using 18F-radiolabeled biologics
    Patent number: 11806409
    Abstract: The invention relates to water soluble 18F-prosthetic groups and the synthesis and use of 18F-labeled biological molecules containing the 18F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
    Type: Grant
    Filed: November 10, 2022
    Date of Patent: November 7, 2023
    Assignee: Bristol-Myers Squibb Company
    Inventors: David Donnelly, David K. Leung
  • IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS
    Publication number: 20230241258
    Abstract: The invention relates to water soluble 18F-prosthetic groups and the synthesis and use of 18F-labeled biological molecules containing the 18F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
    Type: Application
    Filed: November 10, 2022
    Publication date: August 3, 2023
    Inventors: David DONNELLY, David K. LEUNG
  • Imaging methods using F-radiolabeled biologics
    Patent number: 11511000
    Abstract: The invention relates to water soluble 18F-prosthetic groups and the synthesis and use of 18F-labeled biological molecules containing the 18F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: November 29, 2022
    Assignee: Bristol-Myers Squibb Company
    Inventors: David Donnelly, David K. Leung
  • PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
    Publication number: 20220347324
    Abstract: Provided herein are novel 10Fn3 domains which specifically bind to PD-L1, as well as imaging agents based on the same for diagnostics.
    Type: Application
    Filed: April 4, 2022
    Publication date: November 3, 2022
    Inventors: Paul E. MORIN, David DONNELLY, Dasa LIPOVSEK, Jochem GOKEMEIJER, Maria N. JURE-KUNKEL, David FABRIZIO, Martin C. WRIGHT, Douglas DISCHINO, Samuel J. BONACORSI, Jr., Ralph Adam SMITH, Virginie LAFONT, Daniel COHEN, David K. LEUNG
  • PET imaging with PD-L1 binding polypeptides
    Patent number: 11344639
    Abstract: Provided herein are novel 10Fn3 domains which specifically bind to PD-L1, as well as imaging agents based on the same for diagnostics.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: May 31, 2022
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Paul E. Morin, David Donnelly, Dasa Lipovsek, Jochem Gokemeijer, Maria Jure-Kunkel, David Fabrizio, Martin C. Wright, Douglas Dischino, Samuel J. Bonacorsi, Jr., Ralph Adam Smith, Virginie Lafont, Daniel Cohen, David K. Leung
  • IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS
    Publication number: 20210196843
    Abstract: The invention relates to water soluble 18F-prosthetic groups and the synthesis and use of 18F-labeled biological molecules containing the 18F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
    Type: Application
    Filed: March 9, 2021
    Publication date: July 1, 2021
    Inventors: David DONNELLY, David K. LEUNG
  • Imaging methods using 18F-radiolabeled biologics
    Patent number: 10994033
    Abstract: The invention relates to water soluble 18F-prosthetic groups and the synthesis and use 18F-labeled biological molecules containing the 18F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: May 4, 2021
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: David Donnelly, David K. Leung
  • PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
    Publication number: 20190184042
    Abstract: Provided herein are novel 10Fn3 domains which specifically bind to PD-L1, as well as imaging agents based on the same for diagnostics.
    Type: Application
    Filed: May 31, 2017
    Publication date: June 20, 2019
    Inventors: Paul E. MORIN, David DONNELLY, Dasa LIPOVSEK, Jochem GOKEMEIJER, Maria JURE-KUNKEL, David FABRIZIO, Martin C. WRIGHT, Douglas DISCHINO, Samuel J. BONACORSI, Jr., Ralph Adam SMITH, Virginie LAFONT, Daniel COHEN, David K. LEUNG
  • IMAGING METHODS USING 18F-RADIOLABELED BIOLOGICS
    Publication number: 20190184043
    Abstract: The invention relates to water soluble 18F-prosthetic groups and the synthesis and use 18F-labeled biological molecules containing the 18F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
    Type: Application
    Filed: May 31, 2017
    Publication date: June 20, 2019
    Inventors: David DONNELLY, David K. LEUNG